Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
06/13/2002 | WO2002016361A3 Nitrogenous heterocyclic compounds |
06/13/2002 | WO2002008222A3 HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS |
06/13/2002 | WO2001096330A3 Thrombin receptor antagonists |
06/13/2002 | WO2001079198B1 Pyrazoles for inhibiting protein kinase |
06/13/2002 | WO2001072721A3 Synergistic methods and compositions for treating cancer |
06/13/2002 | US20020072618 As organic semiconductors can be dissolved in common organic solvents and applied to the surface of a substrate using inexpensive, low-temperature solution-based processing such as spin-coating, dip-coating, drop-casting, etc. |
06/13/2002 | US20020072616 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
06/13/2002 | US20020072614 For therapy of cardiovascular, cerebrovascular, respiratory and renal disorders |
06/13/2002 | US20020072520 For use in therapy of hyperlipidemia and arteriosclerotic disorders |
06/13/2002 | US20020072517 Substituted cyclic amine metalloprotease inhibitors |
06/13/2002 | DE10061790A1 Flüssigkristalline Verbindungen Liquid-crystalline compounds |
06/13/2002 | DE10059864A1 Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives |
06/13/2002 | CA2436662A1 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
06/13/2002 | CA2431166A1 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
06/13/2002 | CA2431005A1 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
06/13/2002 | CA2430966A1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
06/13/2002 | CA2430951A1 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
06/12/2002 | EP1213288A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
06/12/2002 | EP1212319A2 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
06/12/2002 | EP1212315A1 Novel chalcones |
06/12/2002 | EP1212311A1 Chalcone coumarins |
06/12/2002 | EP1212307A1 Unsaturated oxime ethers and the use thereof for control of harmful fungi and veterinary pests |
06/12/2002 | EP1212303A2 Bicyclic androgen and progesterone receptor modulator compounds and methods |
06/12/2002 | EP1212300A1 Azacycloalkanone serine protease inhibitors |
06/12/2002 | EP1212299A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
06/12/2002 | EP1212269A1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
06/12/2002 | EP1212059A1 Iron chelators and uses thereof |
06/12/2002 | EP0984778B1 Neuropeptide-y ligands |
06/12/2002 | EP0751939B1 Naphthylamides as central nervous system agents |
06/12/2002 | EP0688212B1 C9 taxane derivatives and pharmaceutical compositions containing them |
06/12/2002 | CN1353706A Integrin receptor ligands |
06/12/2002 | CN1353703A tricyclic fused heterocycle compounds, process for preparing the same and use thereof |
06/12/2002 | CN1353695A Heterocyclically substituted benzimidazoles, production and application thereof |
06/11/2002 | US6403810 Thiophene derivatives |
06/11/2002 | US6403794 Reacting a biguanidine with an alkoxycarbonyl, or a substituted triazine with ammonia or an alkylamine |
06/11/2002 | US6403792 Sulfonyl isatin compounds and methods of blocking apoptosis therewith |
06/11/2002 | US6403633 Useful antiangiogenic, antiarthritic, antiinflammatory, antirestenotic, antiinvasive, antimetastic, antiosteoporotic, antiretinopathic, contraceptive and tumoristatic treatment agents |
06/11/2002 | US6403632 Cyclic amide derivative |
06/11/2002 | US6403610 Quinolylpropylpiperidine derivatives, their preparation and the compositions which comprise them |
06/11/2002 | US6403595 Anticoagulants |
06/11/2002 | US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and |
06/11/2002 | US6403577 Hexamethyleneiminyl tachykinin receptor antagonists |
06/11/2002 | US6403573 Compounds of azetidine and pyrrolidin |
06/06/2002 | WO2002044171A1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain |
06/06/2002 | WO2002044170A2 Benzothiophene derivative compounds, process of preparation and use thereof |
06/06/2002 | WO2002044166A1 Substituted quinolines as antitumor agents |
06/06/2002 | WO2002044165A1 Quinoline derivatives as nk-3 antagonists |
06/06/2002 | WO2002044156A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors |
06/06/2002 | WO2002044154A1 Novel compounds |
06/06/2002 | WO2002024665A8 Arylalkane-sulfonamides having endothelin-antagonist activity |
06/06/2002 | WO2002012198A3 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
06/06/2002 | WO2001093841A3 Barbituric acid analogs as therapeutic agents |
06/06/2002 | WO2001087849A3 Modulators of tnf- alpha signaling |
06/06/2002 | WO2001068643A3 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
06/06/2002 | WO2001046147A8 A process for preparing 4-substituted piperidines |
06/06/2002 | US20020068755 Antitumor agents. |
06/06/2002 | US20020068742 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
06/06/2002 | US20020068739 Cholesteryl acyl transferase (ACAT) inhibitors; treatment of hyperlipidaemia and atherosclerosis. |
06/06/2002 | US20020068734 Nitrogen-containing heterocyclic compounds |
06/06/2002 | US20020068681 Substituted thienyl(amino)-sulphonyl(thio)ureas as herbicides |
06/06/2002 | CA2430280A1 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain |
06/06/2002 | CA2429892A1 Benzothiophene derivative compounds, process of preparation and use thereof |
06/05/2002 | EP1211257A2 Metal coordination compound, luminescence device and display apparatus |
06/05/2002 | EP1211250A1 C10 taxane derivatives and pharmaceutical compositions |
06/05/2002 | EP1211249A1 Novel thiazine or pyrazine derivatives |
06/05/2002 | EP1211246A1 Pyrimidine derivatives and herbicides containing the same |
06/05/2002 | EP1211244A2 4,5-substitued imidazolyl compounds for the treatment of inflammation |
06/05/2002 | EP1210343A2 Benzoic acid derivatives and their use as ppar receptor agonists |
06/05/2002 | EP1210335A1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments |
06/05/2002 | EP1210333A2 Novel herbicides |
06/05/2002 | EP1210329A2 Aminoalkoxy carbazoles and their use as 5-ht ligands |
06/05/2002 | EP1210328A1 Fused pyrrolecarboxamides: a new class of gaba brain receptor ligands |
06/05/2002 | EP0966430B1 Anti-inflammatory compounds |
06/05/2002 | EP0891336B1 Substituted 1-methyl-3-benzyluracils |
06/05/2002 | EP0888343B1 Pyrazole-4-yl-hetaroyl derivatives as herbicides |
06/05/2002 | EP0721942B1 Tetracyclic compound |
06/05/2002 | CN1352641A Isonipecotamides for the treatment of integrin mediated disorders |
06/04/2002 | US6399778 Crystalline solvate |
06/04/2002 | US6399774 Compounds having activity as inhibitors of cytochrome P450RAI |
06/04/2002 | US6399771 Cyclic imines as pesticides |
06/04/2002 | US6399656 Using a benzopyran-3-carboxamide compound |
06/04/2002 | US6399653 Ring fused dihydropyrans, process for preparation and use thereof |
06/04/2002 | US6399644 Anticoagulants |
06/04/2002 | US6399641 For therapy and prophylaxis of psychosis, schizophrenia, alzheimer's disease, cognitive disorders and restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries etc. |
06/04/2002 | US6399616 4-(4-(2-(5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl)ethyl)-1 -piperazinyl)furo(3,2-c)pyridine; combined serotonin reuptake inhibitor and partial agonist of 5-ht receptors; reduced latency; depression |
06/04/2002 | US6399606 3-(((2r)-2-(((2-fluorophenyl)amino)carbonylamino)-2-(methoxy carbonyl)ethylthio)methyl)-4-oxo-4-(3-pyridyl)butanoic acid; treatment of chemotherapy induced neuropathy |
06/04/2002 | US6399602 Anticancer agents |
06/04/2002 | US6399598 Diheterocyclic metalloprotease inhibitors |
06/04/2002 | CA2248366C Quinoxalinediones |
06/04/2002 | CA2060557C (quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes |
06/04/2002 | CA2020667C 4-acyloxyquinoline derivatives and insecticidal or acaricidal compositions containing same |
05/30/2002 | WO2002043449A1 Luminescent element material and luminescent element comprising the same |
05/30/2002 | WO2002042289A2 Process for preparing 3-aryl-benzo[b]thiophenes |
05/30/2002 | WO2002042281A1 Substituted 5-aryl and 5-heteroaryl-2-(2-hydroxyphenyl)-2h-benzotriazole derivatives as uv absorbers |
05/30/2002 | WO2002042277A1 Novel compounds for use as hiv protease inhibitors |
05/30/2002 | WO2002042273A2 Acid derivatives useful as serine protease inhibitors |
05/30/2002 | WO2002042272A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
05/30/2002 | WO2002042268A2 Ep4 receptor selective agonists in the treatment of osteoporosis |
05/30/2002 | WO2002041889A2 Indolsulfonyl compounds useful in the treatment of cns disorders |
05/30/2002 | WO2002041835A2 Estrogen receptor modulators |